November, 2012

Change of Director’s Interest Notice: Washer

Change of Director’s Interest Notice: Dantzker

Change of Director’s Interest Notice: Korten

Change of Director’s Interest Notice: Haghighat

Change of Director’s Interest Notice: MacDonald

October, 2012

iSonea Q1 Report 2013

ISN ASX Confirm Rights Issue Shortfall

Notice of Annual General Meeting and Explanatory Memorandum

Dispatch of Renounceable Pro-Rate Rights Issue Prospectus

iSonea Files FDA Submission for Over-the-Counter SonoSentry™

September, 2012

2012 Annual Report

Letter to Eligible Shareholders on Rights Issue

Letter to Ineligible Shareholders on Rights Issue

iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M

Appendix 3B: application for quotation of additional securities and agreement

Prospectus: Offer to Eligible Shareholders

Letter to Option Holders

iSonea App Now Free





Acoustic Asthma Management

The iSonea technology is based on acoustic signal acquisition and processing, and advanced signal processing techniques. Acoustic markers such as wheezes, rhonchi and cough are recorded using propriety lung-sound sensors. These sensors are specifically designed for lung-sound detection and thus are more oriented in detecting sounds characteristic to asthma than normal stethoscopes.

The acquired data is analyzed by iSonea patented algorithms and signal-processing techniques, by mapping out the data’s spectral content in a graphical fashion. The software searches for spectral patterns specific to certain lung sounds, such as wheezes, rhonchi and cough, and marks their presence and duration on the graphical sonogram. Outside noises are cancelled out using patented ambient noise rejection techniques, to ensure the accuracy of physiological sound detection. The user can view a sonogram of the recording and listen to the amplified lung sounds to get a better grasp of the data.

Broncial Provocation Test Display

The criteria for detecting lung sound patterns conform to the guidelines set forth by CORSA (COmputeRized Sound Analysis), the multi-national collaboration that defined and standardized the lung sound terminology. This assures that the detection and quantification results of the PulmoTrack are universally accepted as true lung sound detections.


© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
ISO Certification 2003
US Food & Drug Administration

US Food & Drug Administration
Australian Government

Australian Government
Therapeutic Goods Administration

CE Certification

CE Certification